Answer questions and earn CME/CNE Over the past few decades, a body of research has
emerged confirming what many adult patients with noncentral nervous system cancer have …

Many cancer patients develop treatment-related cognitive dysfunction that affects their
quality of life and can result in diminished functional independence. There is an emerging …

The importance of polymorphisms in the dihydropyrimidine dehydrogenase (DPD) gene
(DPYD) for the prediction of severe toxicity in 5-fluorouracil (5-FU) based chemotherapy has …

Data on prevention and treatment of chemotherapy-induced peripheral neuropathy are
limited. Calcium and magnesium infusions for oxaliplatin administration have the most …

Chemotherapeutic agents may adversely affect the nervous system, including the neural
precursor cells as well as the white matter. Although the mechanisms are not completely …

This review summarizes the adverse effects on the central and/or peripheral nervous
systems that may occur in response to antineoplastic drugs. In particular, we describe the …

It is estimated that more than 1 in 3 individuals will be diagnosed with cancer over their
lifetimes. 1 Advances in treatment have resulted in a growing population of cancer survivors; …

Chemo-brain refers to the thinking and memory problems that occur in cancer patients
during and after chemotherapy. It is also known as cognitive dysfunction or chemo-fog. Risk …

One of the most common complications of chemotherapeutic drugs is toxicity to the central
nervous system (CNS). This toxicity can manifest in many ways, including encephalopathy …

Neurologic complications of conventional cytototxic agents as well as those from
monoclonal antibodies and targeted therapies are increasingly observed in patients with …